Oncology
Cancer clinical trials
Studies of cancers and tumors of every type and site, from prevention to treatment. We’re tracking 20,602 recruiting studies in this area right now.
By phase
- Not applicable9,790
- Phase 24,449
- Phase 12,736
- Phase 1/Phase 21,687
- Phase 31,397
- Phase 2/Phase 3280
- Phase 4263
Top conditions
- Breast Cancer1,227
- Cancer661
- Prostate Cancer654
- Colorectal Cancer491
- Lung Cancer424
- Ovarian Cancer338
- Multiple Myeloma332
- Gastric Cancer296
- Acute Myeloid Leukemia292
- Pancreatic Cancer290
- Hepatocellular Carcinoma283
- Solid Tumor257
- Advanced Solid Tumor255
- Cervical Cancer232
- Head and Neck Cancer227
- Endometrial Cancer206
- Advanced Solid Tumors193
- Esophageal Cancer191
Leading sponsors
- M.D. Anderson Cancer Center450
- Fudan University313
- Sun Yat-sen University290
- Memorial Sloan Kettering Cancer Center288
- National Cancer Institute (NCI)285
- Mayo Clinic240
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences151
- City of Hope Medical Center147
- AstraZeneca134
- University Health Network, Toronto125
Where studies are running
- California1,424
- Texas638
- Arizona513
- Florida448
- Alabama420
- New York409
- Massachusetts343
- Maryland329
- New Jersey269
- Pennsylvania241
Recruiting studies20,602 total
- NCT06521190RecruitingPhase 2
Testing ACOU085 to prevent hearing loss from cisplatin chemotherapy
This trial tests a new drug called ACOU085 to prevent hearing loss in men with testicular cancer who are receiving cisplatin chemotherapy. If you meet the hearing and health criteria, you may be able to join and help see if this drug can protect your hearing.
Tübingen, Baden-WurttembergAges 18–45 - NCT07252076Recruiting
MRI for detecting hidden liver metastases in pancreatic cancer
This trial uses an MRI scan to look for small liver metastases that may not be visible on a CT scan in people newly diagnosed with pancreatic cancer. It aims to improve the accuracy of staging before treatment begins.
Alessandria, PiedmontAges 18 years+ - NCT06124963RecruitingPhase 2
WX390 plus Toripalimab for STK11-mutated cervical cancer
This trial tests a combination of an experimental pill (WX390) and an immunotherapy drug (Toripalimab) for a specific type of cervical cancer that has an STK11 gene change. It aims to see if this combination can shrink tumors or slow the cancer.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06894576Recruiting
Creating a risk score for blood clot recurrence and bleeding in cancer patients
This study is for people with cancer who have had a serious blood clot. Researchers want to create a risk score that predicts who might have another clot or a bleeding problem from treatment, so they can better tailor care.
Ottawa, OntarioAges 18 years+ - NCT05762991Recruiting
AI test to help diagnose stomach bacteria and early stomach changes
This trial checks whether an artificial intelligence (computer) system can help diagnose Helicobacter pylori (a common stomach bacteria) and early stomach “premalignant” changes using endoscopy results. It may help doctors spot problems more accurately when you have a scheduled scope.
TaipeiAges 20–80 - NCT06758882RecruitingPhase 2
Surgery with or without apalutamide for high-risk prostate cancer that has spread a little
This trial tests whether adding the drug apalutamide before and after surgery helps men with high-risk prostate cancer that has spread to a few spots (seen on a special PET scan). You would also receive standard hormone therapy.
Torino, ToAges 18–80 - NCT07247227Recruiting
Sugemalimab plus chemotherapy for advanced lung cancer
This trial tests a new immunotherapy drug (sugemalimab) combined with chemotherapy as a first treatment for advanced non-small cell lung cancer. It aims to see if this combination works well in real-world patients.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07240935Recruiting
A new needs assessment for teens and young adults with cancer
This study is testing a new questionnaire that helps find out what emotional and practical needs teens and young adults with cancer have. Your answers could help doctors better support people your age during treatment.
Barcelona, BarcelonaAges 15–25 - NCT06159166RecruitingPhase 1/Phase 2
Mirdametinib for NF1 skin bumps
This study tests an oral drug called mirdametinib to see if it can shrink skin bumps caused by NF1. If you have at least 24 of these bumps on your skin and are in decent health, you may be able to join.
Baltimore, MarylandAges 18 years+ - NCT05763706Recruiting
Laser treatment for nerve pain after chemotherapy
This trial looks at whether light (photobiomodulation) and laser-like therapy can reduce nerve pain in people who developed neuropathy after chemotherapy. If you match the chemotherapy and language requirements, you may be screened to see if this treatment is safe and helpful for your symptoms.
Hasselt, LimburgAges 18 years+ - NCT05040815RecruitingPhase 2
Sparing inner groin nodes during early anal cancer radiation
This trial tests whether a specific radiation plan that avoids treating the inner groin lymph nodes can treat early-stage anal cancer effectively while reducing side effects. Participants may also receive chemotherapy if they are eligible.
Edmonton, AlbertaAges 18 years+ - NCT06879964Recruiting
Radiation after surgery for high-grade skin cancer
This study looks at whether radiation therapy after surgery helps people with a high-grade type of skin cancer called squamous cell carcinoma. It may help doctors understand who benefits most from this additional treatment.
Pavia, PaviaAges 18 years+ - NCT07244341RecruitingPhase 1
Valemetostat and darolutamide for advanced prostate cancer
This trial tests a new combination of two drugs (valemetostat and darolutamide) for men with metastatic castration-resistant prostate cancer that has worsened after prior treatment. The goal is to see if the combination can slow cancer growth.
La Jolla, CaliforniaAges 18 years+ - NCT06752057Recruiting
Personalized vaccine plus immunotherapy and radiation for advanced lung cancer
This study tests a combination of a personalized vaccine made from your tumor's unique markers, a type of immunotherapy (PD-1 inhibitor), and radiation. The goal is to see if this mix can work better for advanced lung cancer that has progressed after initial treatment.
Nanchang, JiangxiAges 18–70 - NCT07242417RecruitingEarly Phase 1
TC-G203 for adults with GPC3-positive advanced solid tumors
This trial tests an experimental cell therapy (TC-G203) for people with advanced solid tumors that have a specific protein called GPC3. It aims to see if this treatment is safe and effective for those who haven't responded to standard treatments.
Beijing, Beijing MunicipalityAges 18–75 - NCT06261359RecruitingPhase 2
CEND-1 plus chemo for first-line pancreatic cancer
This trial tests a new drug called CEND-1 combined with standard chemotherapy for people with advanced pancreatic cancer that has not been treated before. It aims to see if the combination works better than chemo alone.
Beijing, Beijing MunicipalityAges 18–80 - NCT07660276Enrolling by invitation
AI predicts prostate cancer spread from biopsy
This study uses an artificial intelligence (AI) system to look at prostate biopsy samples and predict if the cancer has spread to the lymph nodes. It may help doctors decide on the best treatment without needing extra surgery or scans.
Changsha, HunanAges 18–90 - NCT06523868Recruiting
Multi-cancer early detection test for military veterans
This trial is testing a blood test that looks for early signs of multiple types of cancer. It is designed for current or former military members who are at least 45 years old and have used VA healthcare. If the test finds something, you would need to be willing to travel to Boston for follow-up.
Boston, MassachusettsAges 45 years+ - NCT06789198RecruitingPhase 1
Peptide Vaccine for Fibrolamellar Cancer and Related Tumors
This trial tests a vaccine designed to target cancer cells with a specific genetic change (DNAJB1-PRKACA). It is for people whose fibrolamellar liver cancer or other tumors with this change are in complete remission after prior treatment, to help prevent the cancer from coming back.
TübingenAges 12 years+ - NCT07240194RecruitingPhase 2
A study of a new drug combo for large B-cell lymphoma with TP53 changes
This trial tests a combination of three drugs (glofitamab, a PD-1 antibody, and lenalidomide) for people with relapsed or refractory large B-cell lymphoma that has a TP53 change. The goal is to see if this combination works better for patients who cannot have a stem cell transplant.
Nanjing, JiangsuAges 18 years+ - NCT06746766Recruiting
Rare cancer registry study in Korea
This study collects information about people with rare cancers in Korea to better understand these diseases. It may help improve future care and treatments.
SeoulAges 19 years+ - NCT07239297Enrolling by invitation
Pathology study using existing patient data
This trial reviews stored tissue slides and medical records to build better computer models for diagnosing diseases. No new treatments are tested.
Guangzhou, GuangdongAges 18–75 - NCT07239115RecruitingPhase 3
Levetiracetam to prevent seizures after brain tumor surgery
This trial tests whether the drug levetiracetam can prevent seizures in people who have brain tumor surgery. If you are having surgery to remove a brain tumor and have never had a seizure, this study may help keep you from having one after the operation.
BeijingAges 18–75 - NCT04993859Recruiting
Testing how chemotherapy affects kids’ urinary markers
This study looks at urinary (bladder and urine) measurements in children who previously had cancer and were treated with certain chemotherapy drugs. It may help researchers understand how past chemotherapy can affect bladder function and related health markers over time.
Aurora, ColoradoAges 5–13
Common questions
- How many cancer clinical trials are recruiting?
- Clin2 is tracking 20,602 recruiting oncology studies from the U.S. registry right now, out of 31,289 we cover in this area in total.
- What does “Cancer” cover here?
- Studies of cancers and tumors of every type and site, from prevention to treatment. We group each study into cancer based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a cancer trial near me?
- Use the search to filter cancer studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.